Literature DB >> 16506035

Chitosan does not reduce post-prandial urinary oxalate excretion.

Joshua Wolf1, John R Asplin, David S Goldfarb.   

Abstract

Chitosan is a positively charged non-absorbable cellulose-like fibrillar biopolymer derived from shellfish which forms films with negatively charged surfaces. We hypothesized that negatively charged oxalate in the intestinal lumen could attach to the positively charged tertiary amino group of chitosan. We studied the effects of chitosan on intestinal oxalate absorption by measuring urinary oxalate excretion following an oral oxalate load with and without accompanying oral chitosan. The subjects consumed a fixed diet and collected urine for 24 h, in divided periods, during control and experimental protocols. Urine was collected with HCl and thymol as a preservative. For the control period, the subjects consumed an oxalate load, 50 g of cooked spinach, with water for lunch; the post-prandial urine collection was divided into three periods of 2 h. For the experimental period, 1 week later, the subjects consumed the same diet as that during the control period, but added 2 g of chitosan to the oxalate load. Post-prandial urinary oxalate excretion was expressed as mg oxalate/g creatinine. The spinach load was associated with a significant post-prandial increase in urinary oxalate during the control period of 25.7+/-12.8 mg/g creatinine. Accompanying the oxalate load with chitosan was well tolerated. There was no decrease in post-prandial urinary oxalate excretion during the experimental period: oxalate excretion rose by 31.3+/-16.9 mg/g creatinine (P=0.57, NS). We conclude that chitosan does not reduce acute intestinal oxalate absorption and therefore does not affect post-prandial urinary oxalate excretion.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16506035     DOI: 10.1007/s00240-006-0048-2

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  17 in total

1.  Comparison of comprehensive and limited metabolic evaluations in the treatment of patients with recurrent calcium urolithiasis.

Authors:  T Yagisawa; P S Chandhoke; J Fan
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

Review 2.  Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria?

Authors:  Bernd Hoppe; Gerd von Unruh; Norbert Laube; Albrecht Hesse; Harmeet Sidhu
Journal:  Urol Res       Date:  2005-11-13

3.  Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.

Authors:  Loris Borghi; Tania Schianchi; Tiziana Meschi; Angela Guerra; Franca Allegri; Umberto Maggiore; Almerico Novarini
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

Review 4.  Role of dietary intake and intestinal absorption of oxalate in calcium stone formation.

Authors:  Ph Jaeger; W G Robertson
Journal:  Nephron Physiol       Date:  2004

Review 5.  Epidemiologic evidence for the role of oxalate in idiopathic nephrolithiasis.

Authors:  G C Curhan
Journal:  J Endourol       Date:  1999-11       Impact factor: 2.942

6.  Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis.

Authors:  M S Pearle; C G Roehrborn; C Y Pak
Journal:  J Endourol       Date:  1999-11       Impact factor: 2.942

Review 7.  Chitosan for overweight or obesity.

Authors:  C Ni Mhurchu; C A E Dunshea-Mooij; D Bennett; A Rodgers
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

8.  Oxalobacter formigenes and its potential role in human health.

Authors:  Sylvia H Duncan; Anthony J Richardson; Poonam Kaul; Ross P Holmes; Milton J Allison; Colin S Stewart
Journal:  Appl Environ Microbiol       Date:  2002-08       Impact factor: 4.792

9.  Influence of magnesium on the absorption and excretion of calcium and oxalate ions.

Authors:  W Berg; C Bothor; W Pirlich; V Janitzky
Journal:  Eur Urol       Date:  1986       Impact factor: 20.096

10.  Hyperoxaluria in patients with recurrent calcium oxalate calculi: dietary and other risk factors.

Authors:  N A Laminski; A M Meyers; M Kruger; M I Sonnekus; L P Margolius
Journal:  Br J Urol       Date:  1991-11
View more
  1 in total

Review 1.  Pharmacology of stone disease.

Authors:  Khashayar Sakhaee
Journal:  Adv Chronic Kidney Dis       Date:  2009-01       Impact factor: 3.620

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.